Literature DB >> 20664339

Evaluation of posteromedial transdiscal superior hypogastric block after failure of the classic approach.

Dina Nabil1, Ali A Eissa.   

Abstract

OBJECTIVE: The iliac crest and L5 transverse process are potential barriers to proper needle placement in superior hypogastric plexus block (SHPB) for pelvic cancer pain. Several investigators report successful SHPB using a paramedian transdiscal approach. Another new single puncture approach, posteromedian transdiscal, has been described which can be performed with the patient in either lateral or prone position.
METHODS: Twenty-two patients were included in the study. Visual analog score, daily morphine consumption, duration of the procedure, side effects, and Quality of Life Questionnaire-C30 were recorded.
RESULTS: The duration of the procedure was 21.4 ± 6.5 minutes. The mean visual analog score, daily morphine consumption, and Quality of Life Questionnaire-C30 score were significantly decreased. There was no neural injury, headache, discitis, or disc herniation.
CONCLUSIONS: The posteromedian transdiscal approach to SHPB for cancer pain proved to be safe and reliable compared with the classic technique. No nerve or disc-related complications were noted.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20664339     DOI: 10.1097/AJP.0b013e3181dedfa9

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  2 in total

1.  Unilateral, single needle approach using an epidural catheter for bilateral superior hypogastric plexus block.

Authors:  Ji Seok Baik; Eun Joo Choi; Pyung Bok Lee; Francis Sahngun Nahm
Journal:  Korean J Pain       Date:  2012-01-02

Review 2.  Inferior Hypogastric Block for the Treatment of Chronic Pelvic Pain.

Authors:  Ivan Urits; Ruben Schwartz; Harish Bangalore Siddaiah; Sathyadev Kikkeri; David Chernobylsky; Karina Charipova; Jai Won Jung; Farnad Imani; Mohsen Khorramian; Giustino Varrassi; Elyse M Cornett; Alan David Kaye; Omar Viswanath
Journal:  Anesth Pain Med       Date:  2021-02-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.